Swedish tech outlet Breakit covered Sigrid’s SEK 45 million funding round, positioning the company as a challenger in the GLP-1 era and outlining its plans for expansion in the United States. The coverage points to strong investor confidence in the market opportunity for SiPore®.
Media Coverage
Ozempic-utmanaren Sigrid Therapeutics backas med 45 miljoner – ska växa i USA
Media: Breakit
Breakit reports on Sigrid’s SEK 45 million funding round and the company’s plans to grow in the US market.
FundingUS expansionGrowth strategy


